Coatue Management LLC Dexcom Inc Transaction History

Coatue Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $1.94 Million - $3.79 Million	28,539 Added 300.0%	38,052 $2.84 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $1.89 Million - $2.61 Million	-20,073 Reduced 67.85%	9,513 $4.87 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $2.7 Million - $3.39 Million	-20,790 Reduced 41.27%	29,586 $15.9 Million
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $40,763 - $54,694	-382 Reduced 0.75%	50,376 $27.5 Million
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $3.34 Million - $4.45 Million	41,245 Added 433.56%	50,758 $21.7 Million
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $2.08 Million - $2.79 Million	-26,713 Reduced 73.74%	9,513 $3.52 Million
Q3 2020 Nov 16, 2020	SELL	$95.51 - $112.95 $12.1 Million - $14.3 Million	-126,651 Reduced 77.76%	36,226 $14.9 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $10.2 Million - $17.2 Million	162,877 New	162,877 $66 Million
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $16.6 Million - $26 Million	-453,063 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $16.1 Million - $19.8 Million	453,063 New	453,063 $67.6 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Coatue Management LLC, based on Form 13F filings with the SEC.

Stay updated on Coatue Management LLC with notifications on news.